PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25331307-0	2014	The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand--a clinical audit.	Metformin	82-91	NADH:ubiquinone oxidoreductase subunit B3	Homo sapiens	30-33	
25331307-1	2014	AIM: Metformin, the most common hypoglycaemic agent used in type 2 diabetes, is associated with reduced serum vitamin B12 concentrations.	Metformin	5-14	NADH:ubiquinone oxidoreductase subunit B3	Homo sapiens	118-121	
25331307-2	2014	This cross sectional observational study determines the prevalence of low vitamin B12 status in people with type 2 diabetes on metformin therapy in both primary and secondary care in New Zealand.	Metformin	127-136	NADH:ubiquinone oxidoreductase subunit B3	Homo sapiens	82-85	
25331307-8	2014	CONCLUSION: Low serum B12 concentration is a common occurrence in people with type 2 Diabetes treated with Metformin.	Metformin	107-116	NADH:ubiquinone oxidoreductase subunit B3	Homo sapiens	22-25